1. Home
  2. NUTX vs RAPP Comparison

NUTX vs RAPP Comparison

Compare NUTX & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$112.00

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$29.33

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
RAPP
Founded
2011
2022
Country
United States
United States
Employees
800
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2009
2024

Fundamental Metrics

Financial Performance
Metric
NUTX
RAPP
Price
$112.00
$29.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$252.50
$47.00
AVG Volume (30 Days)
186.5K
269.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
13971.43
83.64
EPS
8.87
N/A
Revenue
$479,948,633.00
N/A
Revenue This Year
$108.77
N/A
Revenue Next Year
$3.69
N/A
P/E Ratio
$12.91
N/A
Revenue Growth
93.80
N/A
52 Week Low
$40.67
$6.43
52 Week High
$193.07
$42.27

Technical Indicators

Market Signals
Indicator
NUTX
RAPP
Relative Strength Index (RSI) 43.81 55.20
Support Level $106.92 $24.45
Resistance Level $139.71 $29.51
Average True Range (ATR) 8.71 2.11
MACD 2.46 0.18
Stochastic Oscillator 66.79 63.81

Price Performance

Historical Comparison
NUTX
RAPP

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: